Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists: Part I. Risks associated with tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the American …, 2014 - Elsevier
Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists: Part II. Screening for patients on tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the American …, 2014 - Elsevier
Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the American …, 2014 - infona.pl
Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis …

LM Chirch, PR Cataline… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists.

LM Chirch, PR Cataline, KD Dieckhaus, JM Grant-Kels - 2014 - cabidigitallibrary.org
Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the …, 2014 - europepmc.org
A comment on this article appears in" Reply to:" Time to update guidelines on screening for
latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists: Part I. Risks associated with tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the American …, 2014 - jaad.org
Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists: Part II. Screening for patients on tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the American …, 2014 - jaad.org
Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis …

LM Chirch, PR Cataline, KD Dieckhaus… - Journal of the …, 2014 - europepmc.org
A comment on this article appears in" Time to update guidelines on screening for latent
tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa …

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis …

LM Chirch, PR Cataline… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory
conditions, such as psoriasis. Inhibitors of this cytokine are commonly used with significant …